Menu Search
Equities

Acticor Biotech SA

ALACT:PAR

Acticor Biotech SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.31
  • Today's Change-0.03 / -8.82%
  • Shares traded29.44k
  • 1 Year change-94.08%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in EURView more

In 2023, cash reserves at Acticor Biotech SA fell by 2.71m. Cash Flow from Financing totalled 10.36m or -- of revenues. In addition the company used 13.03m for operations while cash used for investing totalled 46.00k.
Cash flow per share-1.48
Price/Cash flow per share--
Book value per share-0.4028
Tangible book value per share-0.4028
More ▼

Balance sheet in EURView more

Acticor Biotech SA has a Debt to Total Capital ratio of 1,047.06%.
Current ratio0.9848
Quick ratio--
Total debt/total equity--
Total debt/total capital10.47
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.